Abstract:We thank Dr Tesarik for his correspondence (Tesarik, 2020Tesarik J. Melatonin: a fertility-friendly anti-corononavirus agent.Reprod. BioMed. 2020; (Online (in this issue))Abstract Full Text Full Text PDF Scopus (1) Google Scholar), stimulated by our recent publication on the potential long-term effects of COVID-19 disease on reproductive health (Li R., et al., 2020Li R. Yin T. Fang F. Li Q. Chen J. Wang Y. Hao Y. Wu G. Duan P. Wang Y. Cheng D. Zhou Q. Zafar M. Xiong C. Li H. Yang J. Qiao J. Potential risks of SARS-CoV-2 infection on reproductive health.Reprod. Biomed. Online. 2020; 41: 89-95Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar). Melatonin (N-acetyl-5-methoxytryptamine) was first reported in 1958 (Lerner et al., 1958Lerner A. Case J. Takahashi Y. Isolation of melatonin, the pineal gland factor that lightens melanocytes.J. Am. Chem. Soc. 1958; : 2587Crossref Scopus (1366) Google Scholar). Although studies on melatonin had already emerged, its function remained underestimated. The main role of melatonin is to mediate dark signals, with possible implications to stabilize circadian rhythms (Cardinali and Pevet, 1998Cardinali D.P. Pevet P. Basic aspects of melatonin action.Sleep Med. Rev. 1998; 2: 175-190Crossref PubMed Scopus (159) Google Scholar). Besides circadian regulation, melatonin may also be effective in the areas of immunomodulation, apoptotic, antioxidant, angiogenic, anticancer properties, anti-proliferative and anti-ageing (Saha et al., 2019Saha S. Singh K.M. Gupta B. Melatonin synthesis and clock gene regulation in the pineal organ of teleost fish compared to mammals: Similarities and differences.Gen. Comp. Endocrinol. 2019; 279: 27-34Crossref PubMed Scopus (37) Google Scholar). Furthermore, melatonin has been demonstrated to play a role in antiviral therapy, for example in infections of encephalitis virus (Silvestri and Rossi, 2013Silvestri M. Rossi G.A. Melatonin: its possible role in the management of viral infections–a brief review.Ital. J. Pediatr. 2013; 39: 61Crossref PubMed Scopus (53) Google Scholar) and respiratory syncytial virus (Huang et al., 2010Huang S.H. Cao X.J. Liu W. Shi X.Y. Wei W. Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice.J. Pineal. Res. 2010; 48: 109-116Crossref PubMed Scopus (78) Google Scholar). Many recent studies also suggest its potential role in treating COVID-19 due to its immune enhancing, antioxidant and anti-inflammation capabilities (Reiter and Ma, 2020Reiter R.J. Ma Q. Treatment of ebola and other infectious diseases: melatonin “goes viral”.Melatonin Research. 2020; 1: 43-57Crossref Google Scholar). Elderly people are a more susceptible population for COVID-19. Melatonin is an age-dependent chemical, which means melatonin levels are lower in older people (Iguichi et al., 1982Iguichi H. Kato K.I. Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects.J. Clin. Endocrinol. Metab. 1982; 55: 27-29Crossref PubMed Scopus (369) Google Scholar). Studies also indicated that the level of melatonin in bats is high which may protect them from coronaviruses (Heideman et al., 1996Heideman P.D. Bhatnagar K.P. Hilton F.K. Bronson F.H. Melatonin rhythms and pineal structure in a tropical bat, Anoura geoffroyi, that does not use photoperiod to regulate seasonal reproduction.J. Pineal. Res. 1996; 20: 90-97Crossref PubMed Scopus (19) Google Scholar). Coronavirus could trigger inflammasome and cause inflammation; melatonin could potentially reduce these complications. Pulmonary fibrosis is the most significant complication of COVID-19. Melatonin may inhibit the regulators of proinflammatory and profibrotic cytokines at the molecular level (Shneider et al., 2020Shneider A. Kudriavtsev A. Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic?.Int. Rev. Immunol. 2020; 39: 153-162Crossref PubMed Scopus (122) Google Scholar). It may also modify endoplasmic reticulum stress and stimulates unfolded protein response through viral infections (Chen et al., 2018Chen Y. Zhao Q. Sun Y. Jin Y. Zhang J. Wu J. Melatonin induces anti-inflammatory effects via endoplasmic reticulum stress in RAW264.7 macrophages.Mol. Med. Rep. 2018; 17: 6122-6129PubMed Google Scholar). In view of the ongoing repeated outbreaks of COVID-19, it is strongly suggested that the collection and analysis of available clinical data on the effectiveness of melatonin is begun immediately. Doctors and scientists should conduct researches to better understand the effectiveness of melatonin and to further illustrate its role in antiviral therapy.

Melatonin levels are low in COVID-19 positive patients and these levels are associated with depression, death anxiety and insomnia

The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

The investigation of relationship between serum melatonin levels with Beck Depression Inventory and Beck Scale for Suicidal Ideation in suicide patients

Efficacy of melatonin in the treatment of patients with COVID‐19: A systematic review and meta‐analysis of randomized controlled trials

Investigating the Effectiveness of Melatonin in the Treatment of Critically Ill Patients with COVID-19 Hospitalized in the Intensive Care Unit: A Double-Blind Randomized Clinical Trial

Altered melatonin secretion and circadian gene expression with increased proinflammatory cytokine expression in early-stage sepsis patients.

Melatonin hormone level in nurses and factors affecting it; Investigation according to shift working pattern

Serum melatonin levels in type 2 diabetic patients with depressive symptoms compared to non-depressed individuals

Clinical Study of Novel Coronavirus Pneumonia Prevention by Melatonin

Melatonin effects on sleep quality of COVID-19 patients: a protocol for systematic review and meta-analysis of randomised controlled trials with trial sequential analysis

Efficacy of Prolonged-Release Melatonin 2 mg (PRM 2 mg) Prescribed for Insomnia in Hospitalized Patients for COVID-19: A Retrospective Observational Study

COVID-19: Melatonin as a potential adjuvant treatment

Melatonin's Impact on Cytokine Storm and Modulation of Purinergic Receptors for COVID-19 Prognosis: A Mental Health Perspective

Anxiety and depression among patients with insomnia during the first wave and the release of the COVID-19 in Northeast China: A cross-sectional survey

Can Melatonin Reduce the Severity of COVID-19 Pandemic?

Insomnia, Anxiety, and Depression During the COVID-19 Pandemic: an International Collaborative Study

Physical and Mental Health Characteristics of Hospitalized COVID-19 Patients with and without Type 2 Diabetes Mellitus in Turkey

Serum melatonin levels and in a sample of Iranian patients with migraine

Circadian Rhythm Disturbance in Acute Ischemic Stroke Patients and Its Effect on Prognosis

Lower Melatonin Indicates Poor Short-term Prognosis in Patients with Acute Ischemic Stroke

Sleep quality, quality of life, fatigue, and mental health in COVID-19 post-pandemic Türkiye: a cross-sectional study